New study aims to stop dangerous bleeding in moms with rare bleeding disorder

NCT ID NCT04146376

Recruiting now Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving a medicine called Wilate to pregnant women with von Willebrand disease can prevent severe bleeding during and after childbirth. About 110 women will receive Wilate to keep their clotting factor levels high enough during delivery. The goal is to find the safest way to manage childbirth and reduce the risk of heavy blood loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary von Willebrand disease Postpartum Hemorrhage von Willebrand disease (hereditary or acquired)

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VON WILLEBRAND DISEASES

Contacts and locations

Locations

Bleeding & Clotting Disorders Institute
RECRUITING

Peoria, Illinois, 61615, United States
Emory University
RECRUITING

Atlanta, Georgia, 30308, United States
Oregon Health & Science University
WITHDRAWN

Portland, Oregon, 97239, United States
The Pennsylvania State University
RECRUITING

Hershey, Pennsylvania, 17033, United States
Tulane University School of Medicine, Louisiana Center for Bleeding and Clotting Disorders
RECRUITING

New Orleans, Louisiana, 70112, United States
University of Colorado
RECRUITING

Aurora, Colorado, 80045, United States
University of Miami
RECRUITING

Miami, Florida, 33136, United States
University of Utah
RECRUITING

Salt Lake City, Utah, 84108, United States
Vanderbilt University
RECRUITING

Nashville, Tennessee, 27232, United States
Washington Center for Bleeding Disorders
RECRUITING

Seattle, Washington, 98104, United States
Yale University
RECRUITING

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.